ClearPoint Neuro | SC 13D/A:超过5%持股股东披露文件(修正)-PTC Therapeutics, Inc.(3.24%)
ClearPoint Neuro | 8-K:重大事件
ClearPoint Neuro | 4:持股变动声明-高管 STIGALL L. JEREMY
ClearPoint Neuro | 4:持股变动声明-高管 D'Alessandro Danilo
ClearPoint Neuro | 4:持股变动声明-高管 BURNETT JOSEPH MICHAEL
ClearPoint Neuro | 10-Q:2024财年二季报
ClearPoint Neuro | 8-K:ClearPoint Neuro公布2024年第二季度业绩
ClearPoint Neuro | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(1.3%)
ClearPoint Neuro | 4:持股变动声明-高管 SABRA MAZIN
ClearPoint Neuro | 4:持股变动声明-高管 STIGALL L. JEREMY
ClearPoint Neuro | 4:持股变动声明-高管 BURNETT JOSEPH MICHAEL
ClearPoint Neuro | 4:持股变动声明-董事 FLETCHER R JOHN
ClearPoint Neuro | 4:持股变动声明-董事 Girin Pascal E R
ClearPoint Neuro | 4:持股变动声明-董事 LIAU LINDA M.
ClearPoint Neuro | 4:持股变动声明-高管 D'Alessandro Danilo
ClearPoint Neuro | 4:持股变动声明-董事 Richards Timothy T.
ClearPoint Neuro | 4:持股变动声明-高管 STIGALL L. JEREMY
ClearPoint Neuro | 4:持股变动声明-高管 D'Alessandro Danilo
ClearPoint Neuro | 4:持股变动声明-高管 BURNETT JOSEPH MICHAEL
ClearPoint Neuro | 4:持股变动声明-高管 SABRA MAZIN
暂无数据